148 related articles for article (PubMed ID: 11154238)
21. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities.
Michel F; Attal-Bonnefoy G; Mangino G; Mise-Omata S; Acuto O
Immunity; 2001 Dec; 15(6):935-45. PubMed ID: 11754815
[TBL] [Abstract][Full Text] [Related]
22. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
23. Altered proximal T-cell receptor signalling events in mouse CD4+ T cells in the presence of anti-CD4 monoclonal antibodies: evidence for reduced phosphorylation of Zap-70 and LAT.
Pullar CE; Morris PJ; Wood KJ
Scand J Immunol; 2003 Apr; 57(4):333-41. PubMed ID: 12662296
[TBL] [Abstract][Full Text] [Related]
24. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
26. T cell effector function and anergy avoidance are quantitatively linked to cell division.
Wells AD; Walsh MC; Sankaran D; Turka LA
J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
[TBL] [Abstract][Full Text] [Related]
27. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras.
Nunès JA; Collette Y; Truneh A; Olive D; Cantrell DA
J Exp Med; 1994 Sep; 180(3):1067-76. PubMed ID: 7520466
[TBL] [Abstract][Full Text] [Related]
28. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
29. Aging impairs induction of cyclin-dependent kinases and down-regulation of p27 in mouse CD4(+) cells.
Tamir A; Miller RA
Cell Immunol; 1999 Nov; 198(1):11-20. PubMed ID: 10612647
[TBL] [Abstract][Full Text] [Related]
30. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta 1 induces antigen-specific unresponsiveness in naive T cells.
Gilbert KM; Thoman M; Bauche K; Pham T; Weigle WO
Immunol Invest; 1997 Jun; 26(4):459-72. PubMed ID: 9246566
[TBL] [Abstract][Full Text] [Related]
32. CD28-specific antibody prevents graft-versus-host disease in mice.
Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
[TBL] [Abstract][Full Text] [Related]
33. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
[TBL] [Abstract][Full Text] [Related]
34. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation.
Utting O; Teh SJ; Teh HS
J Immunol; 2000 Mar; 164(6):2881-9. PubMed ID: 10706673
[TBL] [Abstract][Full Text] [Related]
35. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
[TBL] [Abstract][Full Text] [Related]
36. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
37. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.
Levings MK; Sangregorio R; Galbiati F; Squadrone S; de Waal Malefyt R; Roncarolo MG
J Immunol; 2001 May; 166(9):5530-9. PubMed ID: 11313392
[TBL] [Abstract][Full Text] [Related]
38. Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules.
Nunès JA; Truneh A; Olive D; Cantrell DA
J Biol Chem; 1996 Jan; 271(3):1591-8. PubMed ID: 8576157
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling.
Bonnevier JL; Mueller DL
J Immunol; 2002 Dec; 169(12):6659-63. PubMed ID: 12471093
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells.
Kim JE; White FM
J Immunol; 2006 Mar; 176(5):2833-43. PubMed ID: 16493040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
